John Ramunas
Works at
Rejuvenation Technologies, Inc.
Ceo5 Aug 2026reporter.nih.gov
Grants and prizes
National Center for Advancing Translational Sciences
R44Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinicR44TR0053282024–20275 Aug 2026reporter.nih.gov
National Institute on Alcohol Abuse and Alcoholism
SB1Advancing a telomere extension biologic to treat alcohol-associated liver damage to INDSB1AA0332922026–20281 Jul 2026reporter.nih.gov
National Center for Advancing Translational Sciences
R44Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinicR44TR0053282024–202728 Apr 2025reporter.nih.gov
National Center for Advancing Translational Sciences
R44Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinicR44TR0053282024–202726 Jul 2024reporter.nih.gov